NDC 63323-416-01 - Cisatracurium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-416
- Requested NDC
- 63323-416-01
- Package NDCs from labels
- 63323-416-01, 63323-416-05
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2025-02-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cisatracurium - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-02-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-416-01 | Cisatracurium | 5 mL in 1 VIAL | INJECTION, SOLUTION | 5 | 9 | |
| 63323-416-05 | Cisatracurium | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-416-01 | ML - Milliliter | 63323-416 | a0e10ca9-d28b-45e3-9e90-989e2bf2cb68 | 1 | 2025-08-11 |
| 63323-416-05 | ML - Milliliter | 63323-416 | 843f3271-24f3-4718-b5b0-e42787448e42 | 1 | 2015-08-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CISATRACURIUM BESYLATE | ACTIVE INGREDIENT | 80YS8O1MBS | CISATRACURIUM (CISATRACURIUM BESYLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| CISATRACURIUM | ACTIVE MOIETY | QX62KLI41N | CISATRACURIUM (CISATRACURIUM BESYLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| BENZENESULFONIC ACID | INACTIVE INGREDIENT | 685928Z18A | CISATRACURIUM (CISATRACURIUM BESYLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | CISATRACURIUM (CISATRACURIUM BESYLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0.9% Benzyl Alcohol Solution (Laboratory Use Only) | 0.9% BENZYL ALCOHOL SOLUTION (LABORATORY USE ONLY) | Guangzhou Huanmei Cosmetics Co., Ltd | 5976bde6-0999-ffc4-e063-6394a90aadcf | 2026-08-20 | Warnings | LKG8494WBH |
| Lidocaine Plus Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | CVS Pharmacy | 49003aac-184c-ae33-e063-6294a90a29c0 | 2026-07-24 | Warnings | LKG8494WBH |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Avenacy, LLC | 1c6a8b98-deac-4e25-b4a0-5d0af5090281 | 2026-06-30 | Warnings, Adverse reactions | 199212 80YS8O1MBS |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | LKG8494WBH |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Hospira, Inc. | 67908e20-044d-454d-9c51-bf106e817bd0 | 2026-05-25 | Warnings, Adverse reactions | 1730194 199212 199211 80YS8O1MBS |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, POTASSIUM SORBATE, RESORCINUM, SALICYLICUM ACIDUM, | Energique, Inc. | 2831d28e-9cf1-4a72-9c6c-bb014d059558 | 2026-05-06 | Warnings | LKG8494WBH |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Camber Pharmaceuticals Inc. | d8b5eb77-b393-4cd7-86c5-d2a9d131f96d | 2026-04-30 | Warnings, Adverse reactions | 1730194 199212 199211 80YS8O1MBS |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Somerset Therapeutics, LLC | 23daa1f8-2a07-449d-97a6-11efdb0b9836 | 2026-04-29 | Warnings, Adverse reactions | 199211 80YS8O1MBS |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Somerset Therapeutics, LLC | ed91f65b-e002-43bd-bfa0-5ce8b89119e6 | 2026-04-29 | Warnings, Adverse reactions | 1730194 199212 80YS8O1MBS |
| Walgreens Unscented Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | Walgreen Co. | 41eadb4f-2ca5-42a1-e063-6294a90ab4e2 | 2026-03-04 | Warnings | LKG8494WBH |
| Hepatatox | TRITICUM AESTIVUM, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, GLUTATHIONE, HEPAR SUIS, THYROIDINUM (SUIS), LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, ADRENOCORTICOTROPHIN, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, PHENYL BUTAZONE, PETROLEUM JELLY, PLUMBUM METALLICUM | BioActive Nutritional, Inc | a113a9f1-4792-41a5-8d1b-a6756f356e15 | 2025-12-18 | Warnings | LKG8494WBH |
| Thermacare Max Strength Lidocaine | THERMACARE MAX STRENGTH LIDOCAINE | Clarion Brands LLC | 44fed887-d1e0-d205-e063-6294a90ac416 | 2025-12-02 | Warnings | LKG8494WBH |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Rollon | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF ROLLON | Clarion Brands LLC | 4482d34d-eaca-5522-e063-6394a90a6afb | 2025-11-26 | Warnings | LKG8494WBH |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF GEL | Clarion Brands LLC | 445db02a-c8e8-6ebb-e063-6294a90a4301 | 2025-11-24 | Warnings | LKG8494WBH |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Eugia US LLC | 2cb05c7e-6228-4e2d-a270-7659e3db3fa7 | 2025-11-07 | Warnings, Adverse reactions | 1730194 199211 80YS8O1MBS |
| Zilactin Early Relief Cold Sore | BENZYL ALCOHOL | ASCENT CONSUMER PRODUCTS, INC | 42ef8bfa-c4d9-01cf-e063-6394a90ac88a | 2025-11-06 | Warnings | LKG8494WBH |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Hikma Pharmaceuticals USA Inc. | c5a63679-0c94-4e9d-9ac0-8ee3023bd9a6 | 2025-05-15 | Warnings, Adverse reactions | 1730194 199212 80YS8O1MBS |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Hikma Pharmaceuticals USA Inc. | 46c815f6-7a3d-43a3-b470-3377b126ba09 | 2025-05-15 | Warnings, Adverse reactions | 199211 80YS8O1MBS |
| Cisatracurium besylate | CISATRACURIUM BESYLATE | Gland Pharma Limited | 0bacc37a-5e7f-4f05-9206-56fc8041c1ad | 2025-04-04 | Warnings, Adverse reactions | 1730194 199212 199211 80YS8O1MBS |
| Cisatracurium | CISATRACURIUM BESYLATE | Fresenius Kabi USA, LLC | f78a07e2-0d3b-4460-b29e-8c10c90afbda | 2025-02-21 | Warnings, Adverse reactions | ANDA203183 ANDA203182 63323-417-10 63323-416-01 63323-417-01 63323-418-01 63323-418-20 63323-416-05 63323-418 63323-417 63323-416 63323041601 1730194 199212 199211 0431da49-a804-457c-a823-66d8862db3f2 f78a07e2-0d3b-4460-b29e-8c10c90afbda 80YS8O1MBS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.